ScholarLens Back to search
2016•Acta Scientiarum Naturalium Universitatis SunyatseniRequires access

Analysis of the Efficacy and Safety of Recombinant Tissue Plasminogen Activator for Chinese Patients over 80 Years of Age with Acute Ischemic Stroke： A Pilot Study

Jiandao, Yang, Huazheng, Liang Liang, Yanyan, Сонг, Lingda, Shen, Shaoshi, Wang

Open publisher page 0 citations

Abstract

Dear Editor,Recombinant tissue plasminogen activator(rt-PA)remains the only proven therapy for acute ischemic stroke patients who meet the selection criteria for treatment[1–3].A small number of studies have investigated the efficacy of rt-PA for elderly stroke patients in Japanese and Caucasian populations[4,5].According to the American Heart Association/American Stroke Association Guidelines,

About this research paper

What this paper is about

Dear Editor,Recombinant tissue plasminogen activator(rt-PA)remains the only proven therapy for acute ischemic stroke patients who meet the selection criteria for treatment[1–3].A small number of studies have investigated the efficacy of rt-PA for elderly stroke patients in Japanese and Caucasian populations[4,5].According to the American Heart Association/American Stroke Association Guidelines,

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Dear Editor,Recombinant tissue plasminogen activator(rt-PA)remains the only proven therapy for acute ischemic stroke patients who meet the selection criteria for treatment[1–3].A small number of studies have investigated the efficacy of rt-PA for elderly stroke patients in Japanese and Caucasian populations[4,5].According to the American Heart Association/American Stroke Association Guidelines,

Key concepts: Recombinant tissue plasminogen activator, Medicine, Stroke (engine), Ischemic stroke, Tissue plasminogen activator, Internal medicine, Plasminogen activator, Acute stroke

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Analysis of the Efficacy and Safety of Recombinant Tissue Plasminogen Activator for Chinese Patients over 80 Years of Age with Acute Ischemic Stroke： A Pilot Study — Research Paper | ScholarLens